|
|
42
|
|
|
0521A
|
|
|
ACTINOMYCIN D 500MCG INJ (KWA) DACTINOMYCIN
|
|
|
DACTINOMYCIN
|
|
|
ACTINOMYCIN D
|
|
|
500MCG VIA
|
|
|
BQ
|
|
|
16.72
|
|
|
16.72
|
|
|
500MCG
|
|
|
VIAL
|
|
|
0
|
|
|
|
|
|
KWA
|
|
|
KWALITY PHARMACEUTICALS
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2026-04-01
|
|
|
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
Add to Contract
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
2026-03-02
|